Mordor: Lord of the Trials

The WHO says it will decide by 2019 whether to recommend routine antibiotics for infants in poor countries after a large study—known as the Mordor trial—revealed that receiving 2 annual doses of antibiotics reduced infant mortality by as much as 25%.

Conducted in Malawi, Niger and Tanzania, the study has sparked debate about the potential for antibiotic resistance, but the researchers say the benefits outweigh the risks. A vaccine-style roll-out of azithromycin for infants would likely target 35 million children living in countries where they stand a 1 in 10 chance of dying before age 5.

The New York Times

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top